Your browser doesn't support javascript.
loading
MSH2 promoter hypermethylation in circulating tumor DNA is a valuable predictor of disease-free survival for patients with esophageal squamous cell carcinoma.
Ling, Z Q; Zhao, Q; Zhou, S L; Mao, W M.
Affiliation
  • Ling ZQ; Zhejiang Cancer Research Institute, Zhejiang Province Cancer Hospital, No. 38 Guangji Rd., Banshanqiao District, Hangzhou 310022, PR China. lingzq@hotmail.com
Eur J Surg Oncol ; 38(4): 326-32, 2012 Apr.
Article in En | MEDLINE | ID: mdl-22265839
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Carcinoma, Squamous Cell / Biomarkers, Tumor / DNA Methylation / MutS Homolog 2 Protein Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Eur J Surg Oncol Journal subject: NEOPLASIAS Year: 2012 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Carcinoma, Squamous Cell / Biomarkers, Tumor / DNA Methylation / MutS Homolog 2 Protein Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Eur J Surg Oncol Journal subject: NEOPLASIAS Year: 2012 Document type: Article Country of publication: Reino Unido